CN Patent

CN101784263A — 奈韦拉平的延长释放制剂

Assigned to Boehringer Ingelheim International GmbH · Expires 2010-07-21 · 16y expired

What this patent protects

本发明涉及包含奈韦拉平的延长释放药物组合物。

USPTO Abstract

本发明涉及包含奈韦拉平的延长释放药物组合物。

Drugs covered by this patent

Viramune (NEVIRAPINE) · Boehringer Ingelheim

Patent Metadata

Patent number: CN101784263A
Jurisdiction: CN
Classification: —
Expires: 2010-07-21
Drug substance claim: No
Drug product claim: No
Assignee: Boehringer Ingelheim International GmbH
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.